These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 23425030

  • 1. P21-activated kinase-2 is a critical mediator of transforming growth factor-β-induced hepatoma cell migration.
    Sato M, Matsuda Y, Wakai T, Kubota M, Osawa M, Fujimaki S, Sanpei A, Takamura M, Yamagiwa S, Aoyagi Y.
    J Gastroenterol Hepatol; 2013 Jun; 28(6):1047-55. PubMed ID: 23425030
    [Abstract] [Full Text] [Related]

  • 2. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.
    Wittmann P, Grubinger M, Gröger C, Huber H, Sieghart W, Peck-Radosavljevic M, Mikulits W.
    BMC Cancer; 2015 Nov 16; 15():909. PubMed ID: 26573807
    [Abstract] [Full Text] [Related]

  • 3. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
    Fransvea E, Angelotti U, Antonaci S, Giannelli G.
    Hepatology; 2008 May 16; 47(5):1557-66. PubMed ID: 18318443
    [Abstract] [Full Text] [Related]

  • 4. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L, Sancho P, Bertran E, Fabregat I.
    J Hepatol; 2011 Aug 16; 55(2):351-8. PubMed ID: 21147185
    [Abstract] [Full Text] [Related]

  • 5. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M, Fujisawa J, Inoue K.
    Hepatology; 2000 Aug 16; 32(2):218-27. PubMed ID: 10915727
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K.
    Hepatology; 2009 Apr 16; 49(4):1203-17. PubMed ID: 19263472
    [Abstract] [Full Text] [Related]

  • 7. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 8. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb 17; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M.
    Hepatology; 2010 Sep 17; 52(3):966-74. PubMed ID: 20583212
    [Abstract] [Full Text] [Related]

  • 10. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, Okazaki K, Seki T.
    Hepatology; 2007 Jul 17; 46(1):48-57. PubMed ID: 17596875
    [Abstract] [Full Text] [Related]

  • 11. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY, He JR, Hsu CY, Chen WJ, Bera R, Lin KY, Shih TC, Yu MC, Lin YJ, Chang CJ, Weng WH, Huang SF.
    Hepatology; 2011 Feb 17; 53(2):504-16. PubMed ID: 21246584
    [Abstract] [Full Text] [Related]

  • 12. Altered regulation of Src tyrosine kinase by transforming growth factor beta1 in a human hepatoma cell line.
    Fukuda K, Kawata S, Tamura S, Matsuda Y, Inui Y, Igura T, Inoue S, Kudara T, Matsuzawa Y.
    Hepatology; 1998 Sep 17; 28(3):796-804. PubMed ID: 9731575
    [Abstract] [Full Text] [Related]

  • 13. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta.
    Yen CC, Huang YH, Liao CY, Liao CJ, Cheng WL, Chen WJ, Lin KH.
    J Mol Endocrinol; 2006 Feb 17; 36(1):9-21. PubMed ID: 16461923
    [Abstract] [Full Text] [Related]

  • 14. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 15. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM, Tseng JT, Hong DY, Huang HS.
    Biochem J; 2011 Sep 01; 438(2):349-58. PubMed ID: 21649584
    [Abstract] [Full Text] [Related]

  • 16. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K, Masugi Y, Sakamoto M.
    Dig Dis; 2011 Sep 01; 29(3):284-8. PubMed ID: 21829019
    [Abstract] [Full Text] [Related]

  • 17. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA, Kang MH, Kim JS, Oh SC.
    Carcinogenesis; 2008 Mar 01; 29(3):480-90. PubMed ID: 18174246
    [Abstract] [Full Text] [Related]

  • 18. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X, Rui W, Wu C, He S, Jiang J, Zhang X, Yang Y.
    J Gastroenterol Hepatol; 2014 Jun 01; 29(6):1284-91. PubMed ID: 24329763
    [Abstract] [Full Text] [Related]

  • 19. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
    Damdinsuren B, Nagano H, Kondo M, Natsag J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.
    Oncol Rep; 2006 Feb 01; 15(2):401-8. PubMed ID: 16391861
    [Abstract] [Full Text] [Related]

  • 20. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
    Lu Y, Wu LQ, Li CS, Wang SG, Han B.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 01; 7(2):174-8. PubMed ID: 18397854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.